BIH Visiting Professors
The acquisition of renowned scientists is of particular importance for the BIH. They provide important impulses for the translational research commons of Charité and MDC with their respective background and new ideas. BIH Visiting Professors can be guest scientists from abroad; however, they can also be recruited from Germany and thus promote the national networking.
Prof. Dr. Hans Lehrach
Max Planck Institute for Molecular Genetics, Berlin
Host: Prof. Dr. Erwin Böttinger (BIH)
Research project: "The Future of Healthcare"
Prof. Dr. Peter Van Endert
Université Paris Descartes, France
Host: Peter Kloetzel (Charité)
Research project: "Optimising MHC Class I (Cross-)Presentation to promote tumor rejection by CD8+ T Cells"
Prof. Dr. Robert Frigg
ETH Zurich, Switzerland
Host: Dr. Rolf Zettl (BIH)
Research project: "Förderung von Medizintechnischen Lösungen und deren Translation in Medizinprodukte"
In 2016, for the first time, three BIH Visiting Professors at the BIH were accouned to establish a long-term co-operations in neurobiology, rheumatology and vascular medicine:
Prof. Dr. Hanna Monyer
Universität Heidelberg and Deutsches Krebsforschungszentrum (DKFZ)
Host: Prof. Dr. Dietmar (Charité)
Research project: "Inhibition in the context of cortical columnar organization"
Prof. Dr. Steffen Gay
University of Zurich, Switzerland
Host: Prof. Dr. Gerd-R. Burmester (Charité)
Research project: "Development of novel biomarkers for the detection of response to anti-rheumatic drugs"
PD Dr. Michael Potente
Max-Planck-Institut für Herz- und Lungenforschung, Bad Nauheim
Host: Prof. Dr. Holger Gerhardt (MDC)
Research project: "Mechanisms of vessel size regulation - role of YAP/TAZ signaling"